<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36296272</PMID><DateRevised><Year>2022</Year><Month>10</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2076-2607</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><Issue>10</Issue><PubDate><Year>2022</Year><Month>Oct</Month><Day>10</Day></PubDate></JournalIssue><Title>Microorganisms</Title><ISOAbbreviation>Microorganisms</ISOAbbreviation></Journal><ArticleTitle>The SARS-CoV-2 S1 Spike Protein Promotes MAPK and NF-kB Activation in Human Lung Cells and Inflammatory Cytokine Production in Human Lung and Intestinal Epithelial Cells.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1996</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/microorganisms10101996</ELocationID><Abstract><AbstractText>The coronavirus disease 2019 (COVID-19) pandemic began in January 2020 in Wuhan, China, with a new coronavirus designated SARS-CoV-2. The principal cause of death from COVID-19 disease quickly emerged as acute respiratory distress syndrome (ARDS). A key ARDS pathogenic mechanism is the "Cytokine Storm", which is a dramatic increase in inflammatory cytokines in the blood. In the last two years of the pandemic, a new pathology has emerged in some COVID-19 survivors, in which a variety of long-term symptoms occur, a condition called post-acute sequelae of COVID-19 (PASC) or "Long COVID". Therefore, there is an urgent need to better understand the mechanisms of the virus. The spike protein on the surface of the virus is composed of joined S1-S2 subunits. Upon S1 binding to the ACE2 receptor on human cells, the S1 subunit is cleaved and the S2 subunit mediates the entry of the virus. The S1 protein is then released into the blood, which might be one of the pivotal triggers for the initiation and/or perpetuation of the cytokine storm. In this study, we tested the hypothesis that the S1 spike protein is sufficient to activate inflammatory signaling and cytokine production, independent of the virus. Our data support a possible role for the S1 spike protein in the activation of inflammatory signaling and cytokine production in human lung and intestinal epithelial cells in culture. These data support a potential role for the SARS-CoV-2 S1 spike protein in COVID-19 pathogenesis and PASC.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Forsyth</LastName><ForeName>Christopher B</ForeName><Initials>CB</Initials><Identifier Source="ORCID">0000-0003-4690-7751</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, Section of Gastroenterology, Rush Center for Integrated Microbiome and Chronobiology Research, Department of Anatomy and Cell Biology, Rush University Graduate College, Rush University Medical Center, Chicago, IL 60612, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Lijuan</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Rush Center for Integrated Microbiome and Chronobiology Research, Rush University Medical Center, Chicago, IL 60612, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bhushan</LastName><ForeName>Abhinav</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-8861-9005</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Engineering, Illinois Institute of Technology, Chicago, IL 60616, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Swanson</LastName><ForeName>Barbara</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0001-5973-5720</Identifier><AffiliationInfo><Affiliation>Department of Adult Health &amp; Gerontological Nursing, Rush University Medical Center, Chicago, IL 60612, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Li</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Microbial Pathogens and Immunity, Rush University Medical Center, Chicago, IL 60612, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mamede</LastName><ForeName>Jo&#xe3;o I</ForeName><Initials>JI</Initials><Identifier Source="ORCID">0000-0002-6048-1876</Identifier><AffiliationInfo><Affiliation>Department of Microbial Pathogens and Immunity, Rush University Medical Center, Chicago, IL 60612, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Voigt</LastName><ForeName>Robin M</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Section of Gastroenterology, Rush Center for Integrated Microbiome and Chronobiology Research, Department of Anatomy and Cell Biology, Rush University Graduate College, Rush University Medical Center, Chicago, IL 60612, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shaikh</LastName><ForeName>Maliha</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Rush Center for Integrated Microbiome and Chronobiology Research, Rush University Medical Center, Chicago, IL 60612, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Engen</LastName><ForeName>Phillip A</ForeName><Initials>PA</Initials><AffiliationInfo><Affiliation>Rush Center for Integrated Microbiome and Chronobiology Research, Rush University Medical Center, Chicago, IL 60612, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Keshavarzian</LastName><ForeName>Ali</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Section of Gastroenterology, Rush Center for Integrated Microbiome and Chronobiology Research, Department of Anatomy and Cell Biology, Rush University Graduate College, Rush University Medical Center, Chicago, IL 60612, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>NSF 2031754</GrantID><Agency>National Science Foundation</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>10</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Microorganisms</MedlineTA><NlmUniqueID>101625893</NlmUniqueID><ISSNLinking>2076-2607</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">A549 cells</Keyword><Keyword MajorTopicYN="N">ACE2</Keyword><Keyword MajorTopicYN="N">ARDS</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Caco-2 cells</Keyword><Keyword MajorTopicYN="N">PASC</Keyword><Keyword MajorTopicYN="N">S1 spike protein</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">cytokine storm</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>5</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>9</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>10</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>27</Day><Hour>1</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>10</Month><Day>28</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>10</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36296272</ArticleId><ArticleId IdType="pmc">PMC9607240</ArticleId><ArticleId IdType="doi">10.3390/microorganisms10101996</ArticleId><ArticleId IdType="pii">microorganisms10101996</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zhu N., Zhang D., Wang W., Li X., Yang B., Song J., Zhao X., Huang B., Shi W., Lu R., et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N. Engl. J. Med. 2020;382:727&#x2013;733. doi: 10.1056/NEJMoa2001017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2001017</ArticleId><ArticleId IdType="pmc">PMC7092803</ArticleId><ArticleId IdType="pubmed">31978945</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C., Horby P.W., Hayden F.G., Gao G.F. A novel coronavirus outbreak of global health concern. Lancet. 2020;395:470&#x2013;473. doi: 10.1016/S0140-6736(20)30185-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30185-9</ArticleId><ArticleId IdType="pmc">PMC7135038</ArticleId><ArticleId IdType="pubmed">31986257</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou P., Yang X.L., Wang X.G., Hu B., Zhang L., Zhang W., Si H.R., Zhu Y., Li B., Huang C.L., et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579:270&#x2013;273. doi: 10.1038/s41586-020-2012-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2012-7</ArticleId><ArticleId IdType="pmc">PMC7095418</ArticleId><ArticleId IdType="pubmed">32015507</ArticleId></ArticleIdList></Reference><Reference><Citation>Sohrabi C., Alsafi Z., O&#x2019;Neill N., Khan M., Kerwan A., Al-Jabir A., Iosifidis C., Agha R. World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19) Int. J. Surg. 2020;76:71&#x2013;76. doi: 10.1016/j.ijsu.2020.02.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijsu.2020.02.034</ArticleId><ArticleId IdType="pmc">PMC7105032</ArticleId><ArticleId IdType="pubmed">32112977</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Z., McGoogan J.M. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020;323:1239&#x2013;1242. doi: 10.1001/jama.2020.2648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.2648</ArticleId><ArticleId IdType="pubmed">32091533</ArticleId></ArticleIdList></Reference><Reference><Citation>Worldometer. Coronavirus.  [(accessed on 3 March 2022)].  Available online:  https://www.worldometers.info/coronavirus/</Citation></Reference><Reference><Citation>Moss M., Burnham E.L. Chronic alcohol abuse, acute respiratory distress syndrome, and multiple organ dysfunction. Crit. Care Med. 2003;31:S207&#x2013;S212. doi: 10.1097/01.CCM.0000057845.77458.25.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000057845.77458.25</ArticleId><ArticleId IdType="pubmed">12682442</ArticleId></ArticleIdList></Reference><Reference><Citation>Dickson R.P. The Lung Microbiome and ARDS. It Is Time to Broaden the Model. Am. J. Respir. Crit. Care Med. 2018;197:549&#x2013;551. doi: 10.1164/rccm.201710-2096ED.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201710-2096ED</ArticleId><ArticleId IdType="pmc">PMC6005245</ArticleId><ArticleId IdType="pubmed">29091746</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Valle D.M., Kim-Schulze S., Huang H.H., Beckmann N.D., Nirenberg S., Wang B., Lavin Y., Swartz T.H., Madduri D., Stock A., et al. An inflammatory cytokine signature predicts COVID-19 severity and survival. Nat. Med. 2020;26:1636&#x2013;1643. doi: 10.1038/s41591-020-1051-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-1051-9</ArticleId><ArticleId IdType="pmc">PMC7869028</ArticleId><ArticleId IdType="pubmed">32839624</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris G., Bortolasci C.C., Puri B.K., Marx W., O&#x2019;Neil A., Athan E., Walder K., Berk M., Olive L., Carvalho A.F., et al. The cytokine storms of COVID-19, H1N1 influenza, CRS and MAS compared. Can one sized treatment fit all? Cytokine. 2021;144:155593. doi: 10.1016/j.cyto.2021.155593.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2021.155593</ArticleId><ArticleId IdType="pmc">PMC8149193</ArticleId><ArticleId IdType="pubmed">34074585</ArticleId></ArticleIdList></Reference><Reference><Citation>Que Y., Hu C., Wan K., Hu P., Wang R., Luo J., Li T., Ping R., Hu Q., Sun Y., et al. Cytokine release syndrome in COVID-19: A major mechanism of morbidity and mortality. Int. Rev. Immunol. 2022;41:217&#x2013;230. doi: 10.1080/08830185.2021.1884248.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08830185.2021.1884248</ArticleId><ArticleId IdType="pmc">PMC7919105</ArticleId><ArticleId IdType="pubmed">33616462</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahban M., Stanek A., Hooshmand A., Khamineh Y., Ahi S., Kazim S.N., Ahmad F., Muronetz V., Samy Abousenna M., Zolghadri S., et al. Infection of Human Cells by SARS-CoV-2 and Molecular Overview of Gastrointestinal, Neurological, and Hepatic Problems in COVID-19 Patients. J. Clin. Med. 2021;10:4802. doi: 10.3390/jcm10214802.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10214802</ArticleId><ArticleId IdType="pmc">PMC8584649</ArticleId><ArticleId IdType="pubmed">34768321</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar A., Narayan R.K., Prasoon P., Kumari C., Kaur G., Kumar S., Kulandhasamy M., Sesham K., Pareek V., Faiq M.A., et al. COVID-19 Mechanisms in the Human Body-What We Know So Far. Front. Immunol. 2021;12:693938. doi: 10.3389/fimmu.2021.693938.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.693938</ArticleId><ArticleId IdType="pmc">PMC8592035</ArticleId><ArticleId IdType="pubmed">34790191</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre C.H., Murray B., Varsavsky T., Graham M.S., Penfold R.S., Bowyer R.C., Pujol J.C., Klaser K., Antonelli M., Canas L.S., et al. Attributes and predictors of long COVID. Nat. Med. 2021;27:626&#x2013;631. doi: 10.1038/s41591-021-01292-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., Madhavan M.V., McGroder C., Stevens J.S., Cook J.R., Nordvig A.S., Shalev D., Sehrawat T.S., et al. Post-acute COVID-19 syndrome. Nat. Med. 2021;27:601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramakrishnan R.K., Kashour T., Hamid Q., Halwani R., Tleyjeh I.M. Unraveling the Mystery Surrounding Post-Acute Sequelae of COVID-19. Front. Immunol. 2021;12:686029. doi: 10.3389/fimmu.2021.686029.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.686029</ArticleId><ArticleId IdType="pmc">PMC8278217</ArticleId><ArticleId IdType="pubmed">34276671</ArticleId></ArticleIdList></Reference><Reference><Citation>Letarov A.V., Babenko V.V., Kulikov E.E. Free SARS-CoV-2 Spike Protein S1 Particles May Play a Role in the Pathogenesis of COVID-19 Infection. Biochem. Biokhimiia. 2021;86:257&#x2013;261. doi: 10.1134/S0006297921030032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1134/S0006297921030032</ArticleId><ArticleId IdType="pmc">PMC7772528</ArticleId><ArticleId IdType="pubmed">33838638</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki Y.J., Gychka S.G. SARS-CoV-2 Spike Protein Elicits Cell Signaling in Human Host Cells: Implications for Possible Consequences of COVID-19 Vaccines. Vaccines. 2021;9:36. doi: 10.3390/vaccines9010036.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines9010036</ArticleId><ArticleId IdType="pmc">PMC7827936</ArticleId><ArticleId IdType="pubmed">33440640</ArticleId></ArticleIdList></Reference><Reference><Citation>Theoharides T.C. Could SARS-CoV-2 Spike Protein Be Responsible for Long-COVID Syndrome? Mol. Neurobiol. 2022;59:1850&#x2013;1861. doi: 10.1007/s12035-021-02696-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-021-02696-0</ArticleId><ArticleId IdType="pmc">PMC8757925</ArticleId><ArticleId IdType="pubmed">35028901</ArticleId></ArticleIdList></Reference><Reference><Citation>Lan J., Ge J., Yu J., Shan S., Zhou H., Fan S., Zhang Q., Shi X., Wang Q., Zhang L., et al. Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature. 2020;581:215&#x2013;220. doi: 10.1038/s41586-020-2180-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2180-5</ArticleId><ArticleId IdType="pubmed">32225176</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q., Zhang Y., Wu L., Niu S., Song C., Zhang Z., Lu G., Qiao C., Hu Y., Yuen K.Y., et al. Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2. Cell. 2020;181:894&#x2013;904. doi: 10.1016/j.cell.2020.03.045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.03.045</ArticleId><ArticleId IdType="pmc">PMC7144619</ArticleId><ArticleId IdType="pubmed">32275855</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang J., Ye G., Shi K., Wan Y., Luo C., Aihara H., Geng Q., Auerbach A., Li F. Structural basis of receptor recognition by SARS-CoV-2. Nature. 2020;581:221&#x2013;224. doi: 10.1038/s41586-020-2179-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2179-y</ArticleId><ArticleId IdType="pmc">PMC7328981</ArticleId><ArticleId IdType="pubmed">32225175</ArticleId></ArticleIdList></Reference><Reference><Citation>Duan L., Zheng Q., Zhang H., Niu Y., Lou Y., Wang H. The SARS-CoV-2 Spike Glycoprotein Biosynthesis, Structure, Function, and Antigenicity: Implications for the Design of Spike-Based Vaccine Immunogens. Front. Immunol. 2020;11:576622. doi: 10.3389/fimmu.2020.576622.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.576622</ArticleId><ArticleId IdType="pmc">PMC7575906</ArticleId><ArticleId IdType="pubmed">33117378</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;nez-Flores D., Zepeda-Cervantes J., Cruz-Res&#xe9;ndiz A., Aguirre-Sampieri S., Sampieri A., Vaca L. SARS-CoV-2 Vaccines Based on the Spike Glycoprotein and Implications of New Viral Variants. Front. Immunol. 2021;12:701501. doi: 10.3389/fimmu.2021.701501.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.701501</ArticleId><ArticleId IdType="pmc">PMC8311925</ArticleId><ArticleId IdType="pubmed">34322129</ArticleId></ArticleIdList></Reference><Reference><Citation>Walls A.C., Park Y.J., Tortorici M.A., Wall A., McGuire A.T., Veesler D. Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein. Cell. 2020;181:281&#x2013;292. doi: 10.1016/j.cell.2020.02.058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.02.058</ArticleId><ArticleId IdType="pmc">PMC7102599</ArticleId><ArticleId IdType="pubmed">32155444</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan R., Zhang Y., Li Y., Xia L., Guo Y., Zhou Q. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science. 2020;367:1444&#x2013;1448. doi: 10.1126/science.abb2762.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abb2762</ArticleId><ArticleId IdType="pmc">PMC7164635</ArticleId><ArticleId IdType="pubmed">32132184</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu C., Mendon&#xe7;a L., Yang Y., Gao Y., Shen C., Liu J., Ni T., Ju B., Liu C., Tang X., et al. The Architecture of Inactivated SARS-CoV-2 with Postfusion Spikes Revealed by Cryo-EM and Cryo-ET. Structure. 2020;28:1218&#x2013;1224.e1214. doi: 10.1016/j.str.2020.10.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.str.2020.10.001</ArticleId><ArticleId IdType="pmc">PMC7557167</ArticleId><ArticleId IdType="pubmed">33058760</ArticleId></ArticleIdList></Reference><Reference><Citation>Bar-On Y.M., Flamholz A., Phillips R., Milo R. SARS-CoV-2 (COVID-19) by the numbers. eLife. 2020;9:e57309. doi: 10.7554/eLife.57309.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.57309</ArticleId><ArticleId IdType="pmc">PMC7224694</ArticleId><ArticleId IdType="pubmed">32228860</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogata A.F., Maley A.M., Wu C., Gilboa T., Norman M., Lazarovits R., Mao C.P., Newton G., Chang M., Nguyen K., et al. Ultra-Sensitive Serial Profiling of SARS-CoV-2 Antigens and Antibodies in Plasma to Understand Disease Progression in COVID-19 Patients with Severe Disease. Clin. Chem. 2020;66:1562&#x2013;1572. doi: 10.1093/clinchem/hvaa213.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/clinchem/hvaa213</ArticleId><ArticleId IdType="pmc">PMC7499543</ArticleId><ArticleId IdType="pubmed">32897389</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogata A.F., Cheng C.A., Desjardins M., Senussi Y., Sherman A.C., Powell M., Novack L., Von S., Li X., Baden L.R., et al. Circulating SARS-CoV-2 Vaccine Antigen Detected in the Plasma of mRNA-1273 Vaccine Recipients. Clin. Infect. Dis. 2021;74:715&#x2013;718. doi: 10.1093/cid/ciab465.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab465</ArticleId><ArticleId IdType="pmc">PMC8241425</ArticleId><ArticleId IdType="pubmed">34015087</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki Y.J. The viral protein fragment theory of COVID-19 pathogenesis. Med. Hypotheses. 2020;144:110267. doi: 10.1016/j.mehy.2020.110267.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2020.110267</ArticleId><ArticleId IdType="pmc">PMC7485542</ArticleId><ArticleId IdType="pubmed">33254571</ArticleId></ArticleIdList></Reference><Reference><Citation>Ning Q., Wu D., Wang X., Xi D., Chen T., Chen G., Wang H., Lu H., Wang M., Zhu L., et al. The mechanism underlying extrapulmonary complications of the coronavirus disease 2019 and its therapeutic implication. Signal. Transduct. Target. Ther. 2022;7:57. doi: 10.1038/s41392-022-00907-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-022-00907-1</ArticleId><ArticleId IdType="pmc">PMC8863906</ArticleId><ArticleId IdType="pubmed">35197452</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu H., Chan J.F., Yuen T.T., Shuai H., Yuan S., Wang Y., Hu B., Yip C.C., Tsang J.O., Huang X., et al. Comparative tropism, replication kinetics, and cell damage profiling of SARS-CoV-2 and SARS-CoV with implications for clinical manifestations, transmissibility, and laboratory studies of COVID-19: An observational study. Lancet Microbe. 2020;1:e14&#x2013;e23. doi: 10.1016/S2666-5247(20)30004-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2666-5247(20)30004-5</ArticleId><ArticleId IdType="pmc">PMC7173822</ArticleId><ArticleId IdType="pubmed">32835326</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M., Kleine-Weber H., Schroeder S., Kr&#xfc;ger N., Herrler T., Erichsen S., Schiergens T.S., Herrler G., Wu N.H., Nitsche A., et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020;181:271&#x2013;280.e278. doi: 10.1016/j.cell.2020.02.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.02.052</ArticleId><ArticleId IdType="pmc">PMC7102627</ArticleId><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>Schreiber A., Viemann D., Sch&#xf6;ning J., Schloer S., Mecate Zambrano A., Brunotte L., Faist A., Sch&#xf6;fb&#xe4;nker M., Hrincius E., Hoffmann H., et al. The MEK1/2-inhibitor ATR-002 efficiently blocks SARS-CoV-2 propagation and alleviates pro-inflammatory cytokine/chemokine responses. Cell Mol. Life Sci. 2022;79:65. doi: 10.1007/s00018-021-04085-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-021-04085-1</ArticleId><ArticleId IdType="pmc">PMC8747446</ArticleId><ArticleId IdType="pubmed">35013790</ArticleId></ArticleIdList></Reference><Reference><Citation>Polak S.B., Van Gool I.C., Cohen D., von der Th&#xfc;sen J.H., van Paassen J. A systematic review of pathological findings in COVID-19: A pathophysiological timeline and possible mechanisms of disease progression. Mod. Pathol. 2020;33:2128&#x2013;2138. doi: 10.1038/s41379-020-0603-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41379-020-0603-3</ArticleId><ArticleId IdType="pmc">PMC7306927</ArticleId><ArticleId IdType="pubmed">32572155</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramani R., Laplante J.M., Church T.M., Farrell G.M., Lamson D.M., St George K. CACO-2 cells: A continuous cell line with sensitive and broad-spectrum utility for respiratory virus culture. J. Virol. Methods. 2021;293:114120. doi: 10.1016/j.jviromet.2021.114120.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jviromet.2021.114120</ArticleId><ArticleId IdType="pubmed">33676967</ArticleId></ArticleIdList></Reference><Reference><Citation>Delorey T.M., Ziegler C.G.K., Heimberg G., Normand R., Yang Y., Segerstolpe A., Abbondanza D., Fleming S.J., Subramanian A., Montoro D.T., et al. COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets. Nature. 2021;595:107&#x2013;113. doi: 10.1038/s41586-021-03570-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03570-8</ArticleId><ArticleId IdType="pmc">PMC8919505</ArticleId><ArticleId IdType="pubmed">33915569</ArticleId></ArticleIdList></Reference><Reference><Citation>Cinatl J., Jr., Hoever G., Morgenstern B., Preiser W., Vogel J.U., Hofmann W.K., Bauer G., Michaelis M., Rabenau H.F., Doerr H.W. Infection of cultured intestinal epithelial cells with severe acute respiratory syndrome coronavirus. Cell Mol. Life Sci. 2004;61:2100&#x2013;2112. doi: 10.1007/s00018-004-4222-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-004-4222-9</ArticleId><ArticleId IdType="pmc">PMC7079841</ArticleId><ArticleId IdType="pubmed">15316659</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozer E.A., Simons L.M., Adewumi O.M., Fowotade A.A., Omoruyi E.C., Adeniji J.A., Olayinka O.A., Dean T.J., Zayas J., Bhimalli P.P., et al. Multiple expansions of globally uncommon SARS-CoV-2 lineages in Nigeria. Nat. Commun. 2022;13:688. doi: 10.1038/s41467-022-28317-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-28317-5</ArticleId><ArticleId IdType="pmc">PMC8813984</ArticleId><ArticleId IdType="pubmed">35115515</ArticleId></ArticleIdList></Reference><Reference><Citation>Mamede J.I., Sitbon M., Battini J.L., Courgnaud V. Heterogeneous susceptibility of circulating SIV isolate capsids to HIV-interacting factors. Retrovirology. 2013;10:77. doi: 10.1186/1742-4690-10-77.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-4690-10-77</ArticleId><ArticleId IdType="pmc">PMC3751554</ArticleId><ArticleId IdType="pubmed">23883001</ArticleId></ArticleIdList></Reference><Reference><Citation>Buzhdygan T.P., DeOre B.J., Baldwin-Leclair A., Bullock T.A., McGary H.M., Khan J.A., Razmpour R., Hale J.F., Galie P.A., Potula R., et al. The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in-vitro models of the human blood-brain barrier. Neurobiol. Dis. 2020;146:105131. doi: 10.1016/j.nbd.2020.105131.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2020.105131</ArticleId><ArticleId IdType="pmc">PMC7547916</ArticleId><ArticleId IdType="pubmed">33053430</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki Y.J., Nikolaienko S.I., Dibrova V.A., Dibrova Y.V., Vasylyk V.M., Novikov M.Y., Shults N.V., Gychka S.G. SARS-CoV-2 spike protein-mediated cell signaling in lung vascular cells. Vasc. Pharmacol. 2021;137:106823. doi: 10.1016/j.vph.2020.106823.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vph.2020.106823</ArticleId><ArticleId IdType="pmc">PMC7680014</ArticleId><ArticleId IdType="pubmed">33232769</ArticleId></ArticleIdList></Reference><Reference><Citation>Colunga Biancatelli R.M.L., Solopov P.A., Sharlow E.R., Lazo J.S., Marik P.E., Catravas J.D. The SARS-CoV-2 spike protein subunit S1 induces COVID-19-like acute lung injury in &#x39a;18-hACE2 transgenic mice and barrier dysfunction in human endothelial cells. Am. J. Physiol. Lung Cell Mol. Physiol. 2021;321:L477&#x2013;L484. doi: 10.1152/ajplung.00223.2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajplung.00223.2021</ArticleId><ArticleId IdType="pmc">PMC8384477</ArticleId><ArticleId IdType="pubmed">34156871</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu F., Zhao S., Yu B., Chen Y.M., Wang W., Song Z.G., Hu Y., Tao Z.W., Tian J.H., Pei Y.Y., et al. A new coronavirus associated with human respiratory disease in China. Nature. 2020;579:265&#x2013;269. doi: 10.1038/s41586-020-2008-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2008-3</ArticleId><ArticleId IdType="pmc">PMC7094943</ArticleId><ArticleId IdType="pubmed">32015508</ArticleId></ArticleIdList></Reference><Reference><Citation>Forsyth C.B., Shaikh M., Bishehsari F., Swanson G., Voigt R.M., Dodiya H., Wilkinson P., Samelco B., Song S., Keshavarzian A. Alcohol Feeding in Mice Promotes Colonic Hyperpermeability and Changes in Colonic Organoid Stem Cell Fate. Alcohol. Clin. Exp. Res. 2017;41:2100&#x2013;2113. doi: 10.1111/acer.13519.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/acer.13519</ArticleId><ArticleId IdType="pmc">PMC5711563</ArticleId><ArticleId IdType="pubmed">28992396</ArticleId></ArticleIdList></Reference><Reference><Citation>Giron L.B., Dweep H., Yin X., Wang H., Damra M., Goldman A.R., Gorman N., Palmer C.S., Tang H.Y., Shaikh M.W., et al. Plasma Markers of Disrupted Gut Permeability in Severe COVID-19 Patients. Front. Immunol. 2021;12:686240. doi: 10.3389/fimmu.2021.686240.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.686240</ArticleId><ArticleId IdType="pmc">PMC8219958</ArticleId><ArticleId IdType="pubmed">34177935</ArticleId></ArticleIdList></Reference><Reference><Citation>Cory T.J., Emmons R.S., Yarbro J.R., Davis K.L., Pence B.D. Metformin Suppresses Monocyte Immunometabolic Activation by SARS-CoV-2 Spike Protein Subunit 1. Front. Immunol. 2021;12:733921. doi: 10.3389/fimmu.2021.733921.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.733921</ArticleId><ArticleId IdType="pmc">PMC8631967</ArticleId><ArticleId IdType="pubmed">34858397</ArticleId></ArticleIdList></Reference><Reference><Citation>Paidi R.K., Jana M., Mishra R.K., Dutta D., Pahan K. Selective Inhibition of the Interaction between SARS-CoV-2 Spike S1 and ACE2 by SPIDAR Peptide Induces Anti-Inflammatory Therapeutic Responses. J. Immunol. 2021;207:2521&#x2013;2533. doi: 10.4049/jimmunol.2100144.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.2100144</ArticleId><ArticleId IdType="pmc">PMC8664124</ArticleId><ArticleId IdType="pubmed">34645689</ArticleId></ArticleIdList></Reference><Reference><Citation>Low J.S., Jerak J., Tortorici M.A., McCallum M., Pinto D., Cassotta A., Foglierini M., Mele F., Abdelnabi R., Weynand B., et al. ACE2-binding exposes the SARS-CoV-2 fusion peptide to broadly neutralizing coronavirus antibodies. Science. 2022;377:735&#x2013;742. doi: 10.1126/science.abq2679.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abq2679</ArticleId><ArticleId IdType="pmc">PMC9348755</ArticleId><ArticleId IdType="pubmed">35857703</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaminska B. MAPK signalling pathways as molecular targets for anti-inflammatory therapy&#x2014;From molecular mechanisms to therapeutic benefits. Biochim. Biophys. Acta. 2005;1754:253&#x2013;262. doi: 10.1016/j.bbapap.2005.08.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbapap.2005.08.017</ArticleId><ArticleId IdType="pubmed">16198162</ArticleId></ArticleIdList></Reference><Reference><Citation>Ragab D., Salah Eldin H., Taeimah M., Khattab R., Salem R. The COVID-19 Cytokine Storm; What We Know So Far. Front. Immunol. 2020;11:1446. doi: 10.3389/fimmu.2020.01446.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.01446</ArticleId><ArticleId IdType="pmc">PMC7308649</ArticleId><ArticleId IdType="pubmed">32612617</ArticleId></ArticleIdList></Reference><Reference><Citation>Ombrello M.J., Schulert G.S. COVID-19 and cytokine storm syndrome: Are there lessons from macrophage activation syndrome? Transl. Res. 2021;232:19. doi: 10.1016/j.trsl.2021.03.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trsl.2021.03.002</ArticleId><ArticleId IdType="pmc">PMC7934701</ArticleId><ArticleId IdType="pubmed">33684592</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu T., Zhang L., Joo D., Sun S.-C. NF-&#x3ba;B signaling in inflammation. Signal. Transduct. Target. Ther. 2017;2:17023. doi: 10.1038/sigtrans.2017.23.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sigtrans.2017.23</ArticleId><ArticleId IdType="pmc">PMC5661633</ArticleId><ArticleId IdType="pubmed">29158945</ArticleId></ArticleIdList></Reference><Reference><Citation>Sebastian J.T., Alexander S., Christoph K., Matthias Z., Julia F., Marie-Christine A., Jakob J.M., Jessica G., Sandra W., de Silva U.S., et al. The SARS-CoV-2 spike protein primes inflammasome-mediated interleukin-1-beta secretion in COVID-19 patient-derived macrophages. Res. Sq. 2022 doi: 10.21203/rs.3.rs-30407/v1.</Citation><ArticleIdList><ArticleId IdType="doi">10.21203/rs.3.rs-30407/v1</ArticleId></ArticleIdList></Reference><Reference><Citation>Barilli A., Visigalli R., Ferrari F., Bianchi M.G., Dall&#x2019;Asta V., Rotoli B.M. Immune-Mediated Inflammatory Responses of Alveolar Epithelial Cells: Implications for COVID-19 Lung Pathology. Biomedicines. 2022;10:618. doi: 10.3390/biomedicines10030618.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines10030618</ArticleId><ArticleId IdType="pmc">PMC8945544</ArticleId><ArticleId IdType="pubmed">35327420</ArticleId></ArticleIdList></Reference><Reference><Citation>Vora S.M., Lieberman J., Wu H. Inflammasome activation at the crux of severe COVID-19. Nat. Rev. Immunol. 2021;21:694&#x2013;703. doi: 10.1038/s41577-021-00588-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-021-00588-x</ArticleId><ArticleId IdType="pmc">PMC8351223</ArticleId><ArticleId IdType="pubmed">34373622</ArticleId></ArticleIdList></Reference><Reference><Citation>Freeman T.L., Swartz T.H. Targeting the NLRP3 Inflammasome in Severe COVID-19. Front. Immunol. 2020;11:1518. doi: 10.3389/fimmu.2020.01518.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.01518</ArticleId><ArticleId IdType="pmc">PMC7324760</ArticleId><ArticleId IdType="pubmed">32655582</ArticleId></ArticleIdList></Reference><Reference><Citation>Khani E., Shahrabi M., Rezaei H., Pourkarim F., Afsharirad H., Solduzian M. Current evidence on the use of anakinra in COVID-19. Int. Immunopharmacol. 2022;111:109075. doi: 10.1016/j.intimp.2022.109075.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2022.109075</ArticleId><ArticleId IdType="pmc">PMC9296834</ArticleId><ArticleId IdType="pubmed">35905562</ArticleId></ArticleIdList></Reference><Reference><Citation>Paniri A., Akhavan-Niaki H. Emerging role of IL-6 and NLRP3 inflammasome as potential therapeutic targets to combat COVID-19: Role of lncRNAs in cytokine storm modulation. Life Sci. 2020;257:118114. doi: 10.1016/j.lfs.2020.118114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2020.118114</ArticleId><ArticleId IdType="pmc">PMC7368418</ArticleId><ArticleId IdType="pubmed">32693241</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahman M., Irmler M., Keshavan S., Introna M., Beckers J., Palmberg L., Johanson G., Ganguly K., Upadhyay S. Differential Effect of SARS-CoV-2 Spike Glycoprotein 1 on Human Bronchial and Alveolar Lung Mucosa Models: Implications for Pathogenicity. Viruses. 2021;13:2537. doi: 10.3390/v13122537.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13122537</ArticleId><ArticleId IdType="pmc">PMC8708014</ArticleId><ArticleId IdType="pubmed">34960806</ArticleId></ArticleIdList></Reference><Reference><Citation>Olajide O.A., Iwuanyanwu V.U., Lepiarz-Raba I., Al-Hindawi A.A. Induction of Exaggerated Cytokine Production in Human Peripheral Blood Mononuclear Cells by a Recombinant SARS-CoV-2 Spike Glycoprotein S1 and Its Inhibition by Dexamethasone. Inflammation. 2021;44:1865&#x2013;1877. doi: 10.1007/s10753-021-01464-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10753-021-01464-5</ArticleId><ArticleId IdType="pmc">PMC8050229</ArticleId><ArticleId IdType="pubmed">33860869</ArticleId></ArticleIdList></Reference><Reference><Citation>Olajide O.A., Iwuanyanwu V.U., Adegbola O.D., Al-Hindawi A.A. SARS-CoV-2 Spike Glycoprotein S1 Induces Neuroinflammation in BV-2 Microglia. Mol. Neurobiol. 2022;59:445&#x2013;458. doi: 10.1007/s12035-021-02593-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-021-02593-6</ArticleId><ArticleId IdType="pmc">PMC8551352</ArticleId><ArticleId IdType="pubmed">34709564</ArticleId></ArticleIdList></Reference><Reference><Citation>Corpetti C., Del Re A., Seguella L., Palenca I., Rurgo S., De Conno B., Pesce M., Sarnelli G., Esposito G. Cannabidiol inhibits SARS-Cov-2 spike (S) protein-induced cytotoxicity and inflammation through a PPAR&#x3b3;-dependent TLR4/NLRP3/Caspase-1 signaling suppression in Caco-2 cell line. Phytother. Res. PTR. 2021;35:6893&#x2013;6903. doi: 10.1002/ptr.7302.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ptr.7302</ArticleId><ArticleId IdType="pmc">PMC8662250</ArticleId><ArticleId IdType="pubmed">34643000</ArticleId></ArticleIdList></Reference><Reference><Citation>Wurtz N., Penant G., Jardot P., Duclos N., La Scola B. Culture of SARS-CoV-2 in a panel of laboratory cell lines, permissivity, and differences in growth profile. Eur. J. Clin. Microbiol. Infect. Dis. Off. Publ. Eur. Soc. Clin. Microbiol. 2021;40:477&#x2013;484. doi: 10.1007/s10096-020-04106-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10096-020-04106-0</ArticleId><ArticleId IdType="pmc">PMC7778494</ArticleId><ArticleId IdType="pubmed">33389257</ArticleId></ArticleIdList></Reference><Reference><Citation>de Souza G.A.P., Le Bideau M., Boschi C., Ferreira L., Wurtz N., Devaux C., Colson P., La Scola B. Emerging SARS-CoV-2 Genotypes Show Different Replication Patterns in Human Pulmonary and Intestinal Epithelial Cells. Viruses. 2021;14:23. doi: 10.3390/v14010023.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14010023</ArticleId><ArticleId IdType="pmc">PMC8777977</ArticleId><ArticleId IdType="pubmed">35062227</ArticleId></ArticleIdList></Reference><Reference><Citation>Li T., Yang Y., Li Y., Wang Z., Ma F., Luo R., Xu X., Zhou G., Wang J., Niu J., et al. Platelets mediate inflammatory monocyte activation by SARS-CoV-2 spike protein. J. Clin. Investig. 2022;132:e150101. doi: 10.1172/JCI150101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI150101</ArticleId><ArticleId IdType="pmc">PMC8843740</ArticleId><ArticleId IdType="pubmed">34964720</ArticleId></ArticleIdList></Reference><Reference><Citation>Paidi R.K., Jana M., Raha S., McKay M., Sheinin M., Mishra R.K., Pahan K. Eugenol, a Component of Holy Basil (Tulsi) and Common Spice Clove, Inhibits the Interaction Between SARS-CoV-2 Spike S1 and ACE2 to Induce Therapeutic Responses. J. Neuroimmune Pharmacol. 2021;16:743&#x2013;755. doi: 10.1007/s11481-021-10028-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11481-021-10028-1</ArticleId><ArticleId IdType="pmc">PMC8531902</ArticleId><ArticleId IdType="pubmed">34677731</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma V.K., Prateeksha, Singh S.P., Singh B.N., Rao C.V., Barik S.K. Nanocurcumin Potently Inhibits SARS-CoV-2 Spike Protein-Induced Cytokine Storm by Deactivation of MAPK/NF-&#x3ba;B Signaling in Epithelial Cells. ACS Appl. Bio Mater. 2022;5:483&#x2013;491. doi: 10.1021/acsabm.1c00874.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsabm.1c00874</ArticleId><ArticleId IdType="pubmed">35112841</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoter A., Naim H.Y. Biochemical Characterization of SARS-CoV-2 Spike RBD Mutations and Their Impact on ACE2 Receptor Binding. Front. Mol. BioSci. 2022;9:893843. doi: 10.3389/fmolb.2022.893843.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmolb.2022.893843</ArticleId><ArticleId IdType="pmc">PMC9168323</ArticleId><ArticleId IdType="pubmed">35677879</ArticleId></ArticleIdList></Reference><Reference><Citation>Kircheis R., Planz O. Could a Lower Toll-like Receptor (TLR) and NF-&#x3ba;B Activation Due to a Changed Charge Distribution in the Spike Protein Be the Reason for the Lower Pathogenicity of Omicron? Int. J. Mol. Sci. 2022;23:5966. doi: 10.3390/ijms23115966.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23115966</ArticleId><ArticleId IdType="pmc">PMC9180620</ArticleId><ArticleId IdType="pubmed">35682644</ArticleId></ArticleIdList></Reference><Reference><Citation>Saito A., Irie T., Suzuki R., Maemura T., Nasser H., Uriu K., Kosugi Y., Shirakawa K., Sadamasu K., Kimura I., et al. Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation. Nature. 2022;602:300&#x2013;306. doi: 10.1038/s41586-021-04266-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-04266-9</ArticleId><ArticleId IdType="pmc">PMC8828475</ArticleId><ArticleId IdType="pubmed">34823256</ArticleId></ArticleIdList></Reference><Reference><Citation>Ao Z., Ouyang M.J., Olukitibi T.A., Yao X. SARS-CoV-2 Delta spike protein enhances the viral fusogenicity and inflammatory cytokine production. iScience. 2022;25:104759. doi: 10.1016/j.isci.2022.104759.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2022.104759</ArticleId><ArticleId IdType="pmc">PMC9281453</ArticleId><ArticleId IdType="pubmed">35854977</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J., Xiao T., Cai Y., Lavine C.L., Peng H., Zhu H., Anand K., Tong P., Gautam A., Mayer M.L., et al. Membrane fusion and immune evasion by the spike protein of SARS-CoV-2 Delta variant. Science. 2021;374:1353&#x2013;1360. doi: 10.1126/science.abl9463.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abl9463</ArticleId><ArticleId IdType="pmc">PMC10763652</ArticleId><ArticleId IdType="pubmed">34698504</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou B., Thao T.T.N., Hoffmann D., Taddeo A., Ebert N., Labroussaa F., Pohlmann A., King J., Steiner S., Kelly J.N., et al. SARS-CoV-2 spike D614G change enhances replication and transmission. Nature. 2021;592:122&#x2013;127. doi: 10.1038/s41586-021-03361-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03361-1</ArticleId><ArticleId IdType="pubmed">33636719</ArticleId></ArticleIdList></Reference><Reference><Citation>McCallum M., Czudnochowski N., Rosen L.E., Zepeda S.K., Bowen J.E., Walls A.C., Hauser K., Joshi A., Stewart C., Dillen J.R., et al. Structural basis of SARS-CoV-2 Omicron immune evasion and receptor engagement. Science. 2022;375:864&#x2013;868. doi: 10.1126/science.abn8652.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abn8652</ArticleId><ArticleId IdType="pmc">PMC9427005</ArticleId><ArticleId IdType="pubmed">35076256</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah M., Woo H.G. Omicron: A Heavily Mutated SARS-CoV-2 Variant Exhibits Stronger Binding to ACE2 and Potently Escapes Approved COVID-19 Therapeutic Antibodies. Front. Immunol. 2021;12:830527. doi: 10.3389/fimmu.2021.830527.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.830527</ArticleId><ArticleId IdType="pmc">PMC8819067</ArticleId><ArticleId IdType="pubmed">35140714</ArticleId></ArticleIdList></Reference><Reference><Citation>He C., He X., Yang J., Lei H., Hong W., Song X., Yang L., Li J., Wang W., Shen G., et al. Spike protein of SARS-CoV-2 Omicron (B.1.1.529) variant have a reduced ability to induce the immune response. Signal. Transduct Target. Ther. 2022;7:119. doi: 10.1038/s41392-022-00980-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-022-00980-6</ArticleId><ArticleId IdType="pmc">PMC8994023</ArticleId><ArticleId IdType="pubmed">35397623</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng M.H., Zhang S., Porritt R.A., Noval Rivas M., Paschold L., Willscher E., Binder M., Arditi M., Bahar I. Superantigenic character of an insert unique to SARS-CoV-2 spike supported by skewed TCR repertoire in patients with hyperinflammation. Proc. Natl. Acad. Sci. USA. 2020;117:25254&#x2013;25262. doi: 10.1073/pnas.2010722117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2010722117</ArticleId><ArticleId IdType="pmc">PMC7568239</ArticleId><ArticleId IdType="pubmed">32989130</ArticleId></ArticleIdList></Reference><Reference><Citation>Patterson B.K., Francisco E.B., Yogendra R., Long E., Pise A., Rodrigues H., Hall E., Herrera M., Parikh P., Guevara-Coto J., et al. Persistence of SARS CoV-2 S1 Protein in CD16+ Monocytes in Post-Acute Sequelae of COVID-19 (PASC) up to 15 Months Post-Infection. Front. Immunol. 2021;12:746021. doi: 10.3389/fimmu.2021.746021.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.746021</ArticleId><ArticleId IdType="pmc">PMC8784688</ArticleId><ArticleId IdType="pubmed">35082777</ArticleId></ArticleIdList></Reference><Reference><Citation>Files J.K., Sarkar S., Fram T.R., Boppana S., Sterrett S., Qin K., Bansal A., Long D.M., Sabbaj S., Kobie J.J., et al. Duration of post-COVID-19 symptoms is associated with sustained SARS-CoV-2-specific immune responses. JCI Insight. 2021;6:e151544. doi: 10.1172/jci.insight.151544.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.151544</ArticleId><ArticleId IdType="pmc">PMC8410022</ArticleId><ArticleId IdType="pubmed">34143754</ArticleId></ArticleIdList></Reference><Reference><Citation>Frank M.G., Nguyen K.H., Ball J.B., Hopkins S., Kelley T., Baratta M.V., Fleshner M., Maier S.F. SARS-CoV-2 spike S1 subunit induces neuroinflammatory, microglial and behavioral sickness responses: Evidence of PAMP-like properties. Brain Behav. Immun. 2022;100:267&#x2013;277. doi: 10.1016/j.bbi.2021.12.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.12.007</ArticleId><ArticleId IdType="pmc">PMC8667429</ArticleId><ArticleId IdType="pubmed">34915155</ArticleId></ArticleIdList></Reference><Reference><Citation>Swank Z., Senussi Y., Alter G., Walt D.R. Persistent circulating SARS-CoV-2 spike is associated with post-acute COVID-19 sequelae. medRxiv. 2022 doi: 10.1101/2022.06.14.22276401. Preprint .</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.06.14.22276401</ArticleId><ArticleId IdType="pmc">PMC10169416</ArticleId><ArticleId IdType="pubmed">36052466</ArticleId></ArticleIdList></Reference><Reference><Citation>Raghavan S., Kenchappa D.B., Leo M.D. SARS-CoV-2 Spike Protein Induces Degradation of Junctional Proteins That Maintain Endothelial Barrier Integrity. Front. Cardiovasc. Med. 2021;8:687783. doi: 10.3389/fcvm.2021.687783.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2021.687783</ArticleId><ArticleId IdType="pmc">PMC8225996</ArticleId><ArticleId IdType="pubmed">34179146</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>